Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-42,780.00
% of Total Estimate Gain
-5.49%

Birchview Capital, LP's Sarepta Therapeutics Inc Holding Summary

As of 2025-03-31, Birchview Capital, LP held - shares of Sarepta Therapeutics Inc(SRPT), totaling N/A. This investment constitutes 0% of their stock portfolio, and Birchview Capital, LP now holds 0% of the outstanding Sarepta Therapeutics Inc(SRPT) stock.

The initial trade took place in 2022Q3. And since then Birchview Capital, LP has made 3 purchases of SRPT, at an average price of $111.38, for a total of 7,000.00 shares. In addition, there have been 1 sales at an average price of $105.27 for 7,000.00 shares. Based on historical transaction data and SRPT's current price of $14.08, Birchview Capital, LP's estimated gain on his SRPT holdings is $-42,780.00, reflecting a -5.49% gain to date.

Birchview Capital, LP SRPT ($14.08) Holding Chart

Birchview Capital, LP SRPT ($14.08) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1